Emergy Phaarma Ltd


BSE: 524812 | NSE: NA | ISIN: INE586C01016 
Market Cap: [Rs.Cr.] 1 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Bulk Drugs

 Discuss this stock

Director's Report

EMERGY PHAARMA LIMITED ANNUAL REPORT 2003-2004 DIRECTOR'S REPORT Your Directors present the 11th Annual Report of the Company together with the Audited Accounts for the 12 months' period ended 30th September 2004. FINANCIAL RESULTS: The Financial Results of the Company for the year ended 30th September 2004 are summarised below: (Rs. In lakh) Current Previous Year Year Profit/loss before Depreciation, interest & Tax (-) 11.83 (-) 9.45 Depreciation 32.10 37.04 Profit/ loss before Interest & Tax (-) 43.93 (-) 46.49 Interest Nil Nil Profit/ loss before tax (-) 43.93 (-) 46.49 Income Tax /prior period items Nil Nil Profit /loss after tax (-) 43.93 (-)46.49 Considering the financial position of the Company, your directors are unable to recommend dividend for this year. OPERATIONS: During the period under consideration operations in the plant could not be resumed due to non-availability of working capital. The Company is negotiating with the interested parties for resumption of the operations at the plant. DEPOSITS: The company has not accepted deposits from the public within the meaning of Section 58A of The Companies Act, 1956. DIRECTORS: Mr. A.S.K. Varma Director retires by rotation and being eligible offer himself for reappointment. LISTING AND PAYMENT OF FEE: Equity Shares of the company are listed on Bombay, Delhi, Ahmedabad and Hyderabad Stock Exchanges. The company has paid the listing fees on time. CORPORATE GOVERNANCE: The Corporate Governance in Compliance with Clause 49 of the Listing Agreement is annexed hereto: DIRECTORS' RESPONSIBILITY STATEMENT: Pursuant to Section 217(2AA) of the Companies Act, 1956, the Board hereby certifies and confirms that * In the preparation of Annual Accounts the applicable accounting standards had been followed along with proper explanation relating to material departures. * The Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of your company at the end of the financial year and of the profit or loss of your company for that year. * The Director have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of your company and for preventing and detecting fraud and other irregularities and the Directors have prepared the annual Accounts on a going concern basis. AUDITORS: M/s. Visweswara Rao & Associates, Chartered Accountants, retire at the Eleventh Annual General Meeting and, being eligible, offer themselves for re-appointment. They have confirmed their eligibility and Willingness for being re-appointed. CONSERVATION OF ENERGY/ TECHNOLOGY ABSORPTION / FOREIGN EXCHANGE EARNINGS AND OUTGO: Since there were no operations at plant during the year, there is no consumption of energy. However the company has taken all the necessary steps to conserve the energy. PERSONNEL: None of the employees was in receipt of remuneration as stipulated under Section 217(2A) of the Companies Act, 1956 read with the companies (Particulars of Employees) Rules, 1975. Your company maintained harmonious relationship with all the employees at all levels during the year. ACKNOWLEDGEMENTS: Your Directors thank the Government authorities, financial institutions, Banks, Customers and Suppliers for the kind co-operation and assistance. Your Directors also thank the Shareholders for their continued confidence in the Company. Your Directors also would like to convey their appreciation to all the employees for their dedication. Place: Secunderabad For and on behalf of Board Date : 1st March, 2005 G.M. RAJU Chairman & Managing Director
No Data

Related News

 
No Related News

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Lupin 48,928.14 21.21 7.01 12.61 39.3 49.4 0.07
Divi's Lab. 19,631.07 24.80 6.47 14.99 25.9 32.9 0.02
Jubilant Life 3,073.69 13.50 1.77 15.32 4.2 7.0 1.52
Shilpa Medicare 1,880.32 23.26 3.86 9.81 14.9 14.9 0.25
Vinati Organics 1,778.08 20.64 5.73 5.75 32.1 27.2 0.96
Suven Life Scie. 1,337.94 9.61 5.06 3.88 68.8 67.7 0.50
Granules India 1,288.85 15.91 3.74 5.09 11.7 13.3 0.76
Marksans Pharma 1,254.15 22.60 8.57 4.97 41.9 19.5 0.00
Dishman Pharma. 1,184.68 13.66 1.49 5.90 9.1 11.6 0.72
Sequent Scien. 1,053.22 0.00 26.21 0.00 0.0 0.0 2.06
Hikal 1,028.98 16.06 2.58 8.61 -2.5 5.0 1.57
Shasun Pharma. 990.54 28.11 2.80 9.51 9.6 8.3 1.17
Aarti Drugs 736.83 12.66 2.94 4.35 26.9 21.9 1.39
Nectar Lifesci. 634.77 10.22 0.68 4.00 10.4 12.8 1.16
Orchid Chemicals 551.27 0.00 1.13 16.79 0.0 0.0 3.31

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

A S K Varma , Director 

G Mallapa Raju , Chairman & Managing Director 

G Padma , Director 

VVSN Varma , Director 


Company Head Office / Quarters:
115 Hanumanji Colony,
Brig Sayeed Road Tarbund,
Secunderabad,
Andhra Pradesh-500009
Phone : 91-040-845235/816327
Fax : 91-040-819095
E-mail :
Web : http://
Registrars:
Venture Cap& Corp Inv Ltd
6-2-913/914 3rd Flr
Progressive Towers
Khairtabad
Hyderabad - 500 004

Fund Holding

 
Scheme Name No. of Shares
No data found

Calendar

Jul-2014
M T W T F S S
21 22 23 24 25 26 27
IPO
listIssue Open : Bhanderi Infra.
Economic Events
list Adjusted Merchandise Trade Balance (Yen)
list Merchandise Trade Balance Total (Yen)
Results
list Britannia Inds. | Coromandel Inter | Coromandel Inter | A B B